| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.059 | 0.3 |